CLINICAL_TRIALS
trial_result
· 2011-01-24
Clinical Trial Update: Chest Pain Pilot Study [Phase 3]
Summary
Phase 3 chest pain and gastroesophageal reflux disease trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Chest Pain, Gastroesophageal Reflux | Phase 3 | Status: COMPLETED